Tazemetostat Hydrobromide Patents

Given below is the list of patents protecting Tazemetostat Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tazemetostat Hydrobromide's patents.

Latest Legal Activities on Tazemetostat Hydrobromide's Patents

Given below is the list recent legal activities going on the following patents of Tazemetostat Hydrobromide.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 8th Year, Large Entity	10 Jul, 2024	US9549931
Patent eCofC Notification	11 Jun, 2024	US9394283
Recordation of Patent eCertificate of Correction	11 Jun, 2024	US9394283
Mail Patent eCofC Notification	11 Jun, 2024	US9394283
Email Notification Critical	11 Jun, 2024	US9394283
Payment of Maintenance Fee, 8th Year, Large Entity	05 Jun, 2024	US9522152
Email Notification Critical	17 Apr, 2024	US9889138
Payment of Maintenance Fee, 4th Year, Large Entity	17 Apr, 2024	US10821113
Email Notification Critical	16 Apr, 2024	US9889138
Mail Patent eCofC Notification	16 Apr, 2024	US9889138

Tazemetostat Hydrobromide's Family Patents

Full family tree

Explore Our Curated Drug Screens